Position in ABT
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$328,478
+$59,483 QoQ
Shares Held
3,620
+38.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#431
of 610 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ISTHMUS PARTNERS, LLC holds $28,738,925 across 7 Medical Devices names. ABT ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
|
186,266 | $12,545,015 | |
| 2 | HAE |
Haemonetics Corp
|
65,951 | $4,946,325 | |
| 3 | BFLY |
Butterfly Network, Inc.
|
564,222 | $4,750,749 | |
| 4 | UFPT |
Ufp Technologies Inc
|
12,448 | $3,300,338 | |
| 5 | IRMD |
Iradimed Corp
|
25,586 | $2,444,998 | |
| 6 | HYPR |
Hyperfine, Inc.
|
313,350 | $423,022 | |
| 7 | ABT |
Abbott Laboratories
This page
|
3,620 | $328,478 |
All Filings in ABT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,478 | 3,620 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $268,995 | 2,620 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $328,259 | 2,620 | Shares | Sole | 2026-02-05 | |
| 2025-06-30 | $329,144 | 2,420 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $480,193 | 3,620 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $551,976 | 4,880 | Shares | Sole | 2025-02-07 | |
| 2021-06-30 | $36,402 | 314 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||